Naproxeno Gp (Naproxen)

Naproxen works by non‑selectively inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which blocks the synthesis of prostaglandins. Lower prostaglandin levels reduce inflammation, diminish pain signaling, and help normalize body temperature during fever.

The specific dose of Naproxeno Gp is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and renal or hepatic function. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for naproxen in pregnancy and lactation are limited. It is generally avoided, especially in the third trimester, because of potential fetal cardiovascular effects and reduced milk production. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the Naproxeno Gp product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both naproxen and ibuprofen are NSAIDs that inhibit COX enzymes, but naproxen has a longer half‑life, allowing less frequent dosing, while ibuprofen is shorter‑acting. Naproxen may carry a slightly higher risk of gastrointestinal irritation, whereas ibuprofen is often preferred for short‑term use. Choice depends on clinical judgment and patient tolerance.

Naproxeno Gp should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Naproxeno Gp is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food or milk may reduce gastrointestinal discomfort. Patients should swallow tablets whole and not crush or chew them unless specifically instructed.

The most serious risks include gastrointestinal bleeding or ulcer perforation, severe cardiovascular events such as myocardial infarction or stroke, acute renal failure, severe liver injury, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of bleeding, severe abdominal pain, or skin rash.

Naproxeno Gp should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active peptic ulcer disease, severe renal or hepatic impairment, uncontrolled hypertension, and in the third trimester of pregnancy. It is also contraindicated in patients receiving certain anticoagulants or those with a history of serious cardiovascular events without medical supervision.